Neurochemical and Neurobehavioral Effects of Neonatal Administration of β-N-Methylamino-l-Alanine and 3,3′-Iminodipropionitrile

Neurotoxicology and Teratology - Tập 20 - Trang 181-192 - 1998
R Dawson1, E.G Marschall1, K.C Chan1, W.J Millard1, B Eppler1, T.A Patterson2
1Department of Pharmacodynamics, College of Pharmacy, JHMHC Box 100487, University of Florida, Gainesville, FL USA
2Division of Neurotoxicology, National Center for Toxicological Research/FDA, 3900 NCTR Road, Jefferson, AR USA

Tài liệu tham khảo

Ali, 1993, Development of dopamine and N-methyl-d-aspartate systems in rat brain, Brain Res. Dev. Brain Res., 73, 25, 10.1016/0165-3806(93)90042-9 Allen, 1993, β-N-methylamino-l-alanine in the presence of bicarbonate is an agonist at non-N-methyl-d-aspartate-type receptors, Neuroscience, 54, 567, 10.1016/0306-4522(93)90228-8 Amano, 1992, Regulation of nerve growth factor and nerve growth factor receptor production by NMDA in C6 glioma cells, Mol. Brain Res., 14, 35, 10.1016/0169-328X(92)90007-X Aruffo, 1987, Low doses of L-monosodium glutamate promote neuronal growth and differentiation in vitro, Dev. Neurosci., 9, 228, 10.1159/000111625 Badger, 1982, Hypothalamic–pituitary function in adult rats treated neonatally with monosodium glutamate, Endocrinology, 111, 2031, 10.1210/endo-111-6-2031 Balazs, 1988, Stimulation of the N-methyl-d-aspartate receptor has a trophic effect on differentiating cerebellar granule cells, Neurosci. Lett., 87, 80, 10.1016/0304-3940(88)90149-8 Balazs, 1988, N-methyl-d-aspartate promotes the survival of cerebellar granule cells in culture, Neuroscience, 27, 437, 10.1016/0306-4522(88)90279-5 Bourguignon, 1992, Neuroendocrine mechanism of onset of puberty. Sequential reduction in activity of inhibitory and facilitatory N-methyl-d-aspartate receptors, J. Clin. Invest., 90, 1736, 10.1172/JCI116047 Bradford, 1976, A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Brenneman, 1990, N-methyl-d-aspartate receptors influence neuronal survival in developing spinal cord cultures, Brain Res. Dev. Brain Res., 51, 63, 10.1016/0165-3806(90)90258-Z Brewer, 1989, NMDA receptor regulation of neuronal morphology in cultured hippocampal neurons, Neurosci. Lett., 99, 268, 10.1016/0304-3940(89)90458-8 Cadet, 1989, The iminodipropionitrile (IDPN)-induced dyskinetic syndrome, Neurosci. Biobehav. Rev., 13, 39, 10.1016/S0149-7634(89)80050-8 Cadet, 1987, Clonidine and prazosin block the iminodipropionitrile (IDPN)-induced spasmodic dyskinetic syndrome in mice, Pharmacol. Biochem. Behav., 26, 791, 10.1016/0091-3057(87)90612-5 Cadet, 1988, Central and peripheral effects of iminodipropionitrile on catecholamine metabolism in rats, Synapse, 2, 23, 10.1002/syn.890020105 Choi, 1992, Excitotoxic cell death, J. Neurobiol., 23, 1261, 10.1002/neu.480230915 Choi, 1987, Glutamate neurotoxicity in cortical cell culture, J. Neurosci., 7, 357, 10.1523/JNEUROSCI.07-02-00357.1987 Clark, 1987, Catecholamines and attention I, Neurosci. Biobehav. Rev., 11, 341, 10.1016/S0149-7634(87)80006-4 Clough, 1986, Monosodium glutamate neurotoxicity, Brain Res. Bull., 17, 51, 10.1016/0361-9230(86)90160-7 Comer, 1982, Effects of perinatal methimazole exposure on a developmental test battery for neurobehavioral toxicity in rats, Toxicol. Appl. Pharmacol., 63, 133, 10.1016/0041-008X(82)90032-1 Copani, 1990, β-N-methylamino-l-alanine (l-BMAA) is a potent agonist of ‘metabolotropic’ glutamate receptors, Eur. J. Pharmacol., 181, 327, 10.1016/0014-2999(90)90100-K Crofton, 1991, Auditory deficits and motor dysfunction following iminodipropionitrile administration in the rat, Neurotoxicol. Teratol., 13, 575, 10.1016/0892-0362(91)90040-4 Crofton, 1993, Developmental neurotoxicity following neonatal exposure to 3,3′-iminodipropionitrile in the rat, Neurotoxicol. Teratol., 15, 117, 10.1016/0892-0362(93)90070-5 Dawson, 1986, Developmental and sex-specific effects of low dose neonatal monosodium glutamate administration on mediobasal hypothalamic chemistry, Neuroendocrinology, 42, 158, 10.1159/000124268 Dawson, 1985, Neonatal monosodium glutamate administration alters noradrenergic measures in the brainstem of the mouse, Brain Res. Bull, 15, 117, 10.1016/0361-9230(85)90127-3 Dawson, 1989, Central and peripheral actions of alpha2-adrenergic agonists on renal function in Long–Evans and Brattleboro rats, Pharmacology, 39, 240, 10.1159/000138604 Dawson, 1992, Taurine content in tissues from aged Fischer-344 rats, Age, 15, 73, 10.1007/BF02435005 Dawson, 1993, Regulation of phosphate-activated glutaminase (PAG) by glutamate analogues, Neurochem. Res., 18, 125, 10.1007/BF01474674 Dawson, 1986, Hypothalamic monoamine metabolism in mice, Pharmacology, 32, 25, 10.1159/000138149 Dawson, 1995, Mechanism of sodium nitroprusside-mediated inhibition of aromatic amino acid decarboxylase activity, Pharmacology, 50, 74, 10.1159/000139269 Dawson, 1989, A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium l-glutamate (MSG), Pharmacol. Biochem. Behav., 32, 391, 10.1016/0091-3057(89)90168-8 Duncan, 1991, 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood–brain barrier permeability in the rat, J. Pharmacol. Exp. Ther., 258, 27 Fisher, 1991, The postweaning housing environment determines expression of learning deficit associated with neonatal monosodium glutamate (M.S.G.), Neurotoxicol. Teratol., 13, 507, 10.1016/0892-0362(91)90058-5 Frieder, 1987, Prenatal monosodium glutamate causes long-lasting cholinergic and adrenergic changes in various brain regions, J. Neurochem., 48, 1359, 10.1111/j.1471-4159.1987.tb05672.x Gad, 1982, A neuromuscular screen for use in industrial toxicology, J. Toxicol. Environ. Health, 9, 691, 10.1080/15287398209530197 Gianutsos, 1985, Neurochemical effects of IDPN on the mouse brain, Neurotoxicology, 6, 159 Gorter, 1992, Hippocampal neuronal responsiveness to NMDA agonists and antagonists in the adult rat neonatally treated with MK-801, Brain Res., 572, 176, 10.1016/0006-8993(92)90467-N Gorter, 1992, Chronic neonatal NMDA receptor blockade with MK-801 alters monoamine metabolism in the adult rat, Neurosci. Lett., 137, 97, 10.1016/0304-3940(92)90307-S Insel, 1990, The ontogeny of excitatory amino acid receptors in rat forebrain-I. N-methyl-d-aspartate and quisqualate receptors, Neuroscience, 35, 31, 10.1016/0306-4522(90)90117-M Kleinschmidt, 1987, Blockade of “NMDA” receptors disrupts experience-dependent plasticity of kitten striate cortex, Science, 238, 355, 10.1126/science.2443978 Komuro, 1993, Modulation of neuronal migration by NMDA receptors, Science, 260, 95, 10.1126/science.8096653 Lorden, 1986, Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse, Neurobehav. Toxicol. Teratol., 8, 509 Lorden, 1980, Forebrain norepinephrine and the selective processing of information, Brain Res., 190, 569, 10.1016/0006-8993(80)90301-7 MacDonald, 1990, Peripubertal treatment with N-methyl-d-aspartic acid or neonatally with monosodium glutamate accelerates sexual maturation in female rats, an effect reversed by MK-801, Neuroendocrinology, 52, 143, 10.1159/000125565 Malessa, 1991, Amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, 54, 984, 10.1136/jnnp.54.11.984 Marani, 1982, Monosodium glutamate accelerates migration of hypothalamic perikarya at puberty, Histochemistry, 75, 145, 10.1007/BF00496005 Mason, 1979, Theories of the dorsal bundle extinction effect, Brain Res. Rev., 1, 107, 10.1016/0165-0173(79)90018-3 McDonald, 1990, Physiological and pathophysiological roles of excitatory amino acids during central nervous system development, Brain Res. Rev., 15, 41, 10.1016/0165-0173(90)90011-C Millard, 1982, Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor, Endocrinology, 110, 540, 10.1210/endo-110-2-540 Miller, 1990, The ontogeny of excitatory amino acid receptors in the rat forebrain-II. Kainic acid receptors, Neuroscience, 35, 45, 10.1016/0306-4522(90)90118-N Mitsumoto, 1995, Animal models of amyotrophic lateral sclerosis, 73 Moser, 1993, Prolonged neurobehavioral and visual effects of short-term exposure to 3,3′-iminodipropionitrile (IDPN) in rats, Fundam. Appl. Toxicol., 21, 277, 10.1006/faat.1993.1100 Overmann, 1979, Neurobehavioral ontogeny of neonatally lead-exposed rats. I. Reflex development and somatic indices, Neurotoxicology, 1, 125 Patel, 1982, The activities in different neural cell types of certain enzymes associated with the metabolic compartmentation glutamate, Brain Res., 256, 3, 10.1016/0165-3806(82)90091-8 Pearce, 1987, Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells, FEBS Lett., 223, 143, 10.1016/0014-5793(87)80525-2 Perez, 1979, Minimal tissue concentrations of glutamate required to produce necrosis of hypothalamic neurons in newborn mice, Biol. Neonate, 35, 17, 10.1159/000241149 Plaitakis, 1988, The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis, Ann. Neurol., 24, 446, 10.1002/ana.410240314 Rakonczay, 1991, Effects of L-β-N-methylamino-l-alanine (l-BMAA) on the cortical cholinergic and glutamatergic systems of the rat, J. Neurosci. Res., 29, 121, 10.1002/jnr.490290114 Richter, 1989, l-β-methylaminoalanine inhibits [3H]glutamate binding in the presence of bicarbonate ions, Brain Res., 492, 385, 10.1016/0006-8993(89)90925-6 Rose, 1987, Evidence for reorganization of the neuroendocrine centres regulating pulsatile LH secretion in rats receiving neonatal monosodium-l-glutamate treatment, J. Endocrinol., 113, 261, 10.1677/joe.0.1130261 Ross, 1987, Specific antagonism of excitotoxic action of ‘uncommon’ amino acids assayed in organotypic mouse cortical cultures, Brain Res., 425, 120, 10.1016/0006-8993(87)90490-2 Rothstein, 1992, Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis, N. Engl. J. Med., 326, 1464, 10.1056/NEJM199205283262204 Sayre, 1985, Pathogenesis of experimental giant neurofilamentous axonopathies, Brain Res. Rev., 10, 69, 10.1016/0165-0173(85)90008-6 Schneider, 1981, The effect of the neurolathyrogenic substance β,β′-iminodipropionitrile (IDPN) on some biological parameters in rats and mice, Gen. Pharmacol., 12, 109, 10.1016/0306-3623(81)90108-7 Schulze, 1991, A neurotoxicity screening battery for use in safety evaluation, Fundam. Appl. Toxicol., 16, 602, 10.1016/0272-0590(91)90099-P Seawright, 1990, Selective degeneration of cerebellar cortical neurons caused by cycad neurotoxin, l-β-methylaminoalanine (l-BMAA), in rats, Neuropathol. Appl. Neurobiol., 16, 153, 10.1111/j.1365-2990.1990.tb00944.x Smith, 1992, Facilitated transport of the neurotoxin, β-N-methylamino-l-alanine, across the blood–brain barrier, J. Neurochem., 58, 1330, 10.1111/j.1471-4159.1992.tb11346.x Spencer, 1987, Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin, Science, 237, 517, 10.1126/science.3603037 Sun, 1991, Sex-specific impairment in sexual and ingestive behaviors of monosodium glutamate-treated rats, Physiol. Behav., 50, 873, 10.1016/0031-9384(91)90408-G Takanashi, 1993, Free amino acids and activities of folate-derivative converting enzymes in nervous system of rats administered with beta, betar-iminodipropionitrile, Rinsho Shinkeigaku, 33, 862 Tombaugh, 1990, Hippocampal glutamine synthetase, Am. J. Physiol., 258, E894 Tsai, 1991, Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS, Brain Res., 556, 151, 10.1016/0006-8993(91)90560-I Van Den Buuse, 1985, Effects of neonatal treatment with monosodium-glutamate in spontaneously hypertensive rats, Brain Res., 351, 135, 10.1016/0165-3806(85)90239-1 Wallace, 1990, Effect of age and monosodium-l-glutamate (MSG) treatment on neurotransmitter content in brain regions from male Fischer-344 rats, Neurochem. Res., 15, 889, 10.1007/BF00965908 Weiss, 1988, Beta-N-methylamino-l-alanine neurotoxicity, Science, 241, 973, 10.1126/science.3136549 Weiss, 1989, Neurotoxicity of β-N-methylamino-l-alanine (BMAA) and β-N-oxalylamino-l-alanine (BOAA) on cultured cortical neurons, Brain Res., 497, 64, 10.1016/0006-8993(89)90970-0 Yeh, 1994, Effect of growth hormone administration and treadmill exercise on serum and skeletal muscle IGF-1 in rats, Am. J. Physiol., 266, E129 Zafra, 1991, Interplay between glutamate and γ-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons, Proc. Natl. Acad. Sci. USA, 88, 10037, 10.1073/pnas.88.22.10037